Skip to Main Content

Paper Details

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC.
Lung Cancer
3
2022
Author NameAffiliation
Frances A ShepherdPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Ming-Sound TsaoToronto General Hospital, University Health Network, University of Toronto
Joerg SchwockToronto General Hospital, University Health Network, University of Toronto
  • 1 - 4

Datasets